PL
PharmAdva, LLC
SEC filingManufacturing · Rochester, NY
Amount raised$550Ksold at filing
Total offering$1M$450K still open
Investors in the raise2count reported to the SEC
FiledJan 23, 2026first sale Jan 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jim BrushDirector
Michael BergExecutive Officer, Director
Michael AllenDirector
Joel ReiserDirector
Jonathan SacksDirector
Pamela SchwitzerDirector
Mark AmbrusterDirector
Executive officers, directors and promoters as listed on the Form D.